Small Molecules
1 February 2016
Oryzon Receives Approval in Spain to Initiate Phase I for ORY-2001 for Alzheimer’s Disease1 February 2016
Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT40129 January 2016
Avanir Pharmaceuticals Announces FDA Approval of ONZETRA™ Xsail™ (AVP-825) for the Acute Treatment of Migraine in Adults29 January 2016
U.S. FDA approves Eisai’s anticancer agent Halaven® for the treatment of advanced liposarcoma29 January 2016
Actelion receives positive CHMP opinion for Uptravi (selexipag) for the long-term treatment of pulmonary arterial hypertension29 January 2016
Allergan’s Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)28 January 2016
AbbVie Initiates Enrollment in Phase 3 Clinical Program for Elagolix in Patients with Uterine Fibroids27 January 2016
FDA Approves Takeda’s Dexilant SoluTab (dexlansoprazole)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports